Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

lumiracoxib

Known as: 2-((2-chloro-6-Fluorophenyl)amino)-5-methylbenzeneacetic acid, 2-(2-((2-chloro-6-fluoro-phenyl)amino)-5-methyl-phenyl)acetic acid, Lumiracoxibum 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2011
Review
2011
OBJECTIVE To analyse the available evidence on cardiovascular safety of non-steroidal anti-inflammatory drugs. DESIGN Network… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 3
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Lumiracoxib is a selective cyclooxygenase-2 inhibitor developed for the symptomatic treatment of osteoarthritis and acute pain… Expand
  • figure 1
  • table 2
  • figure 2
Is this relevant?
Highly Cited
2007
Highly Cited
2007
BACKGROUND Evidence suggests that both selective cyclooxygenase (COX)-2 inhibitors and non-selective non-steroidal anti… Expand
Is this relevant?
Review
2007
Review
2007
Selective COX-2 inhibitors (coxibs) are approved for the relief of acute pain and symptoms of chronic inflammatory conditions… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
Is this relevant?
Review
2006
Review
2006
CONTEXT Adverse effects of selective cyclooxygenase 2 (COX-2) inhibitors on renal events and arrhythmia have been controversial… Expand
Is this relevant?
Highly Cited
2005
Highly Cited
2005
1. This manuscript presents the preclinical profile of lumiracoxib, a novel cyclooxygenase-2 (COX-2) selective inhibitor. 2… Expand
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Highly Cited
2004
BACKGROUND The potential for cyclo-oxygenase 2 (COX2)-selective inhibitors to increase the risk for myocardial infarction is… Expand
Is this relevant?
Highly Cited
2004
Highly Cited
2004
The coxibs are a subclass of nonsteroidal antiinflammatory drugs (NSAIDs) designed to inhibit selectively cyclooxygenase-2 (COX-2… Expand
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the… Expand
Is this relevant?